St Jude Financial Ratios

St Jude Medical Inc -- USA Stock  

USD 80.82  0.01  0.0124%

Use fundamental data analysis to confirm all available fundamental indicators of St Jude Medical to find out if markets are now mispricing the corporation. We found twenty-nine available financial indicators for St Jude which can be compared to its peers in the sector. To make sure the equity is not overpriced, please validate all St Jude Medical Inc fundamentals including its Shares Owned by Insiders, Cash per Share, Working Capital, as well as the relationship between Price to Sales and Earnings Per Share . Given that St Jude Medical has Number of Shares Shorted of 8.18 M, we advise you double-check St Jude latest market performance to make sure the company can sustain itself next year.Use St Jude to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of St Jude to be traded at $84.86 in 30 days

St Jude Medical Valuation Over Time

Enterprise Value

St Jude Company Summary

St Jude competes with Edwards Lifesciences, Digirad, and DarioHealth Corp. It operates in two divisions Implantable Electronic Systems and Cardiovascular and Ablation Technologies. St Jude Medical Inc offers tachycardia implantable cardioverter defibrillator systems and cardiac resynchronization therapy defibrillator devices to treat patients with tachycardia. It also offer atrial fibrillation solutions comprising electrophysiology introducers and catheters advanced cardiac mapping navigation and recording systems and ablation systems and pacemakers which deliver lowvoltage electrical impulses to stimulate a heartbeat for patients whose hearts beat too slowly. In addition St Jude Medical Inc offers vascular closure devices compression assist devices pressure measurement guidewires diagnostic coronary imaging technology percutaneous catheter introducers diagnostic guidewires heart failure monitoring devices renal denervation technology and vascular plugs optical coherence tomography imaging products and other vascular accessories as well as CardioMEMS a heart failure monitoring device. Further it offer structural heart products including heart valve replacement and repair products and structural heart defect devices neuromodulation products such as spinal cord stimulation and radiofrequency ablation to treat chronic pain as well as deep brain stimulation to treat movement disorders and thoratec solutions comprising ventricular assist devices and percutaneous heart pumps. St Jude Medical Inc sells its solutions through direct sales force and independent distributors. St. Jude Medical Inc. was founded in 1976 and is headquartered in St. Paul Minnesota.

St Jude Cash Flow from Operations vs Number of Employees

St Jude Medical Inc is currently regarded as top stock in cash flow from operations category among related companies. It is currently regarded as top stock in number of employees category among related companies . The ratio of Cash Flow from Operations to Number of Employees for St Jude Medical Inc is about  57,722 

St Jude Market Fundamentals

 Change(%) 0.0124%
< 50% 

Chance of Financial Distress

St Jude Medical Inc has    50 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info


St Jude Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth


Compare St Jude To Peers
Michael Rousseau CEO and President COO and Director
Sarah Bates Non-Executive Chairman of the Board
More Executives

Opportunity Range

December 13, 2017 Opportunity Range